Department of Digestive Surgery, Archet II Hospital, Nice, France.
University of Nice-Sophia-Antipolis, Nice, France.
Int J Colorectal Dis. 2019 Oct;34(10):1795-1799. doi: 10.1007/s00384-019-03367-2. Epub 2019 Aug 27.
We report a case of successful management of complex recurrent cryptoglandular fistula-in-ano by surgery combined with autologous bone marrow-derived mesenchymal stroma cells (MSCs) and platelet-rich plasma (PRP) injection.
Clinical, radiological, and surgical data of the patient were reviewed, as well as the current literature on complex fistula-in-ano.
A 37-year-old man with a recurrent cryptoglandular perianal fistula was addressed to our department. Inflammatory bowel disease was excluded by clinical history, endoscopy, and blood tests. Physical examination and MRI showed an anterior external orifice on the midline, 5 cm from the anal verge, with an internal orifice on the same line. Surgery combined to injection of MSC-PRP solution was successfully performed. MSC-PRP solution was prepared while the patient was under general anesthesia: bone marrow MSCs were obtained by centrifugation of a tibial puncture specimen and PRP from a peripheral whole blood sample of the patient. There were no adverse events post-operatively. Clinical and MRI examination 4 months after treatment confirmed the absence of perianal fistula. More than 2 years after surgery, there has been no recurrence.
Treatment of complex recurrent cryptoglandular fistula-in-ano by surgery combined to autologous bone marrow-derived MSCs and PRP injection seems safe in selected patients, allowing long-term healing. This procedure seems promising but further evaluation by clinical trials is warranted.
我们报告一例成功通过手术联合自体骨髓间充质基质细胞(MSCs)和富含血小板的血浆(PRP)注射治疗复杂复发性肛隐窝腺源性瘘的病例。
回顾了患者的临床、放射学和手术数据,并对复杂肛隐窝瘘的当前文献进行了综述。
一名 37 岁男性,患有复发性肛隐窝腺源性肛瘘,被收入我科。通过临床病史、内镜和血液检查排除了炎症性肠病。体格检查和 MRI 显示中线距肛门缘 5cm 处有一个前外部开口,有一个相同线上的内部开口。成功进行了手术联合 MSC-PRP 溶液注射。在患者全身麻醉下制备 MSC-PRP 溶液:通过对胫骨穿刺标本进行离心获得骨髓间充质干细胞,从患者外周全血样本中获得 PRP。术后无不良事件发生。治疗后 4 个月的临床和 MRI 检查证实肛旁瘘不存在。手术后 2 年多,无复发。
在选择的患者中,手术联合自体骨髓源性 MSCs 和 PRP 注射治疗复杂复发性肛隐窝腺源性瘘似乎是安全的,可以实现长期愈合。该手术方法有前景,但需要临床试验进一步评估。